Cargando…
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs (lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We therefore performed RNA sequencing on paired metastatic/non-metastatic PCa xenografts derived from clinical specimens. The most...
Autores principales: | Crea, Francesco, Watahiki, Akira, Quagliata, Luca, Xue, Hui, Pikor, Larissa, Parolia, Abhijit, Wang, Yuwei, Lin, Dong, Lam, Wan L., Farrar, William L., Isogai, Takao, Morant, Rudolf, Castori-Eppenberger, Serenella, Chi, Kim N., Wang, Yuzhuo, Helgason, Cheryl D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996663/ https://www.ncbi.nlm.nih.gov/pubmed/24519926 |
Ejemplares similares
-
Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
por: Crea, Francesco, et al.
Publicado: (2015) -
The non-coding transcriptome as a dynamic regulator of cancer metastasis
por: Crea, Francesco, et al.
Publicado: (2013) -
Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2013) -
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
por: Parolia, Abhijit, et al.
Publicado: (2015) -
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
por: Cicenas, Jonas, et al.
Publicado: (2010)